Top 50 Medical Device VC Funds & Investors in Belgium (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
PMV
VC Fund
|
7 | Belgium, United States, The Netherlands | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1M–$43M |
|
Capricorn Partners
VC Fund
|
6 | Belgium, The Netherlands, United States | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$45M |
|
White Fund
VC Fund
|
5 | Belgium, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Medical Device | $4.1M–$12M |
|
S.R.I.W.
VC Fund
|
5 | Belgium, United States, Spain | Venture - Series Unknown, Series A | Health Care, Biotechnology, Manufacturing | $422k–$51M |
|
Meusinvest (Noshaq)
VC Fund
|
5 | Belgium, France, Germany | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $137k–$16M |
|
WING by Digital Wallonia
VC Fund
|
3 | Belgium | Seed, Convertible Note, Series A | Software, Health Care, SaaS | $61k–$12M |
|
Vives Louvain Technology Fund
VC Fund
|
3 | Belgium, France, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $156k–$125M |
|
Namur Invest
VC Fund
|
3 | Belgium, United States | Series A, Seed, Grant | Health Care, Medical Device, Auctions | $658k–$18M |
|
Newton Biocapital
VC Fund
|
3 | Belgium, Japan, France | Series A, Venture - Series Unknown, Seed | Biotechnology, Medical, Pharmaceutical | $1.3M–$84M |
|
imec.istart Future Fund
VC Fund
|
3 | Belgium, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Satellite Communication | $1.2M–$5.7M |
|
Sambrinvest
VC Fund
|
2 | Belgium, France, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $544k–$49M |
|
Carevolution
VC Fund
|
2 | Belgium, United States | Seed | Health Care, Medical Device, Medical | $1.2M–$4.5M |
|
TCD Capital
VC Fund
|
2 | Belgium, France | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical Device | $2.1M–$19M |
|
imec.xpand
VC Fund
|
2 | Belgium, United States, Germany | Seed, Series A, Series B | Semiconductor, Manufacturing, Medical Device | $3.3M–$100M |
|
UI Investissement
VC Fund
|
2 | France, Spain, Canada | Private Equity, Seed, Series A | Manufacturing, Software, Health Care | $1.5M–$49M |
|
GoBeyond
VC Fund
|
2 | Switzerland, Germany, United Kingdom | Seed, Series A | Software, Health Care, Information Technology | $544k–$5M |
|
CAREvolution
VC Fund
|
2 | Belgium, United States | Seed, Venture - Series Unknown | Health Care, Medical Device, GovTech | $1.2M–$4.5M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
Amazon Alexa Fund
VC Fund
|
2 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $120k–$96M |
|
Inventures SA
VC Fund
|
2 | Belgium, France, United Kingdom | Series A, Seed, Series B | Health Care, Software, Biotechnology | $82k–$21M |
|
Spreds
VC Fund
|
2 | Belgium, France | Seed, Series A, Pre-Seed | Information Technology, Software, Health Care | $150k–$2.5M |
|
Spinventure
VC Fund
|
2 | Belgium | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $768k–$15M |
|
Sensinnovat
VC Fund
|
2 | Belgium, France | Seed, Series A, Series B | Health Care, Manufacturing, Medical Device | $5.2M–$17M |
|
Manuardeo
VC Fund
|
1 | Belgium, United States | Series A, Series B, Venture - Series Unknown | TV, Video, Mobile | |
|
New Rhein
VC Fund
|
1 | United States, Israel, Belgium | Series A, Series B, Series C | Medical, Biotechnology, Health Care | $7M–$197M |
|
Financière Spin-Off Luxembourgeoise
VC Fund
|
1 | Belgium | Seed, Series A | Health Care, Medical, Therapeutics | $1.4M–$4.3M |
|
Delta Partners
VC Fund
|
1 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $795k–$6.6M |
|
Sofinex
VC Fund
|
1 | Belgium | Series A | Wellness, Lifestyle, Health Care | |
|
Parana Management
VC Fund
|
1 | Belgium | Series A, Series B | Medical, Diabetes, Health Care | |
|
Lumiares
VC Fund
|
1 | Belgium | Pre-Seed | Software, Health Care, Manufacturing | |
|
Elaia
VC Fund
|
1 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
Nausicaa Ventures
VC Fund
|
1 | Belgium | Series B | Software, CRM, Big Data | |
|
EIC Fund
VC Fund
|
1 | Germany, The Netherlands, Austria | Pre-Seed, Seed | Biotechnology, Health Care, Information Technology | |
|
Sofinnova Investments
VC Fund
|
1 | United States, France, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $7.3M–$150M |
|
Samsara BioCapital
VC Fund
|
1 | United States, United Kingdom, Canada | Series B, Series A, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $33M–$200M |
|
Qbic Fund
VC Fund
|
1 | Belgium, The Netherlands | Seed, Series A | Biotechnology, Software, Health Care | $1.3M–$34M |
|
SFPI-FPIM
VC Fund
|
1 | Belgium, United States, The Netherlands | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $4.3M–$250M |
|
SHIGERU AG
VC Fund
|
1 | United States, Japan, Belgium | Seed, Pre-Seed, Series A | Blockchain, Cloud Computing, Virtual Reality | $1M–$7.3M |
|
Investsud
VC Fund
|
1 | Belgium, France | Series A, Seed, Series B | Biotechnology, Medical, Health Care | $546k–$29M |
|
Thuja Capital
VC Fund
|
1 | The Netherlands, Belgium, United States | Series A, Seed | Biotechnology, Medical, Health Care | |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Omega Funds
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $14M–$208M |
|
LeanSquare
VC Fund
|
1 | Belgium, France, United States | Seed, Venture - Series Unknown, Series A | Software, Music, Information Technology | $257k–$19M |
|
Theodorus III
VC Fund
|
1 | Belgium, Canada, France | Series A, Seed, Venture - Series Unknown | Health Care, Biotechnology, Software | $566k–$41M |
|
EQT Life Sciences
VC Fund
|
1 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.3M–$165M |
|
Qbic
VC Fund
|
1 | Belgium | Seed, Series B | Health Care, Biotechnology, AgTech | $3.7M–$12M |
|
Karista
VC Fund
|
1 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $768k–$33M |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.4M–$75M |
|
Fonds Vives II (University of Louvain, UCL)
VC Fund
|
1 | Belgium, United States | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $6.6M–$75M |
| Access all 143 VC funds in Belgium Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Do and dare company
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 158
- Round size: Seed $1M–$4M; Series A $3M–$40M; Series B $6.6M–$43M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Borro — Cashless deposit system
- Storm — Storm is een producent van hernieuwbare energie. Samen met ons team ontwikkelen, bouwen en exploiteren we duurzame energieprojecten over het hele land: van wind- en zonneparken tot snellaadstations en batterijopslag. Dit telkens tegen een zo laag mogelijke maatschappelijke kost.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: Belgium, The Netherlands, United States
Investor stats
- Total investments: 121
- Round size: Series A $3.3M–$18M; Series B $5.3M–$45M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $53M in 2025
Portfolio highlights
- Endo Tools Therapeutics — Endo Tools Therapeutics is dedicated to the development of innovative devices that provide therapeutic interventions for gastric conditions
- Delft Advanced Biorenewables — We enable the bio-economy by improving the productivity of fermentations with our in-situ product recovery (ISPR) technology.
- Trillium Renewable Chemicals — Trillium Renewable Chemicals manufactures chemicals from renewable feedstocks used in a variety of industrially important applications. The company was founded in 2021 and based in Knoxville, Tennessee.
For game changers in medtech
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Belgium, United States
Investor stats
- Total investments: 12
- Round size: Seed $4.1M–$11M; Series A $5.3M–$12M; Venture - Series Unknown $5.5M–$11M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — raised $22M in 2019
Portfolio highlights
- neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Series A
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 111
- Round size: Series A $422k–$31M; Venture - Series Unknown $2.7M–$51M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Univercells — Mix parlay, atau lebih dikenal sebagai parlay bola atau hanya parlay, merupakan taruhan judi bola online yang menggabungkan minimal 2 hingga 10 tim pertandingan sepak bola menjadi 1 tiket taruhan.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Santero Therapeutics — This is the homepage of the website
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 79
- Round size: Seed $137k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $2M–$16M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Convertible Note, Series A
- Geography: Belgium
Investor stats
- Total investments: 37
- Round size: Seed $377k–$1.9M; Series A $1.1M–$12M; Convertible Note $61k–$570k
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- IONNYK — Discover IONNYK, the ePaper Digital Art Frame for art and personal photography, combining Electronic Paper (E Ink), patented technology and elegant home design.
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 27
- Round size: Seed $1.6M–$7.3M; Series A $156k–$49M; Series B $4.7M–$125M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $38M in 2020
Portfolio highlights
- BOTALYS — BOTALYS uses an innovative Biomimetic Indoor Farming technology to recreate the ideal wild conditions for rare botanicals to grow in. We develop pristine & potent botanical ingredients for the Nutraceutical and Cosmetic industries.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Namur Invest Group provides companies with financing solutions in various forms adapted to their needs, to strengthen their financial.
Show more...Investment focus
- Industry: Health Care, Medical Device, Auctions
- Stage:Series A, Seed, Grant
- Geography: Belgium, United States
Investor stats
- Total investments: 8
- Round size: Series A $658k–$18M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Invineo — Invineo design and development of a "smart machine" for catering and hospitality professionals.
- VolitionRx — We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Belgium, Japan, France
Investor stats
- Total investments: 22
- Round size: Seed $2.9M–$3.2M; Series A $6.1M–$84M; Venture - Series Unknown $1.3M–$20M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely still investing — raised $57M in 2022
Portfolio highlights
- Bioxodes — Bioxodes is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics to prevent thrombotic events without hemorrhagic risk.
- Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
imec.istart Future Fund is an independent early-stage venture capital fund.
Show more...Investment focus
- Industry: Health Care, Medical Device, Satellite Communication
- Stage:Seed, Pre-Seed, Series A
- Geography: Belgium, United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $1.2M–$5.7M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
- nxgsat — We build interoperable satellite networks.
- OnTracx — OnTracx measures and manages the load your body experiences, step by step. Our sensor captures real-time load during any run, bringing lab-level precision to real-world conditions. The app empowers runners to monitor their progress, while OnTracx Pro gives professionals the tools for load screenings, training program creation, and effortless athlete follow-up.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Belgium, France, Spain
Investor stats
- Total investments: 40
- Round size: Seed $544k–$24M; Series A $987k–$49M; Series B $4.4M–$45M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Brenus Pharma — Brenus Pharma develops off-the-shelf, next-generation in vivo immunotherapies designed to unlock the immune response against solid tumors.
- Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Offers health consulting services
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Belgium, United States
Investor stats
- Total investments: 3
- Round size: Seed $1.2M–$4.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Helpper — Helpper verbindt mensen die thuishulp zoeken voor dagelijkse taken, met hulpvaardige buurtbewoners die een centje willen bijverdienen.
- Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Belgium, France
Investor stats
- Total investments: 18
- Round size: Series A $2.1M–$7.7M; Series B $13M–$19M; Venture - Series Unknown $5.5M–$6.5M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $49M in 2021
Portfolio highlights
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- Inpulse — Inpulse is an automated supply management platform for restaurateurs.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Expanding nanotechnology into business.
Show more...Investment focus
- Industry: Semiconductor, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, Germany
Investor stats
- Total investments: 54
- Round size: Seed $3.3M–$23M; Series A $9.1M–$56M; Series B $12M–$100M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $322M in 2024
Portfolio highlights
- Invisix — Invisix shrinks the metrology wavelength with soft x-ray light to measure next-gen 3D chips and extend Moore's law for semiconductor makers.
- Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
- NEURA Robotics — Cognitive Robotics for Real-World Applications: NEURA Robotics enables safe and smart robot integration for Industry, Work and Everyday Life
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Private Equity, Seed, Series A
- Geography: France, Spain, Canada
Investor stats
- Total investments: 107
- Round size: Seed $1.5M–$5.8M; Series A $3.2M–$33M; Private Equity $3.2M–$49M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $39M in 2021
Portfolio highlights
- Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
- Brenus Pharma — Brenus Pharma develops off-the-shelf, next-generation in vivo immunotherapies designed to unlock the immune response against solid tumors.
- B Capital Partners — B Capital Partners is a financial services firm offering investment advisory solutions with a focus on infrastructure and clean energy.
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 181
- Round size: Seed $544k–$5M; Series A $1.2M–$4.5M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
- Stylect — Stylect is a mobile app to to help women discover their perfect shoe. They aggregate products from multiple websites and based on users' preferences (that they gather through a hot-or-not interface), they recommend better products. Their users are able to keep track of and buy the products they like and receive notifications whenever a productthey love goes on sale. Finally, They use geolocation to let their users know when a shoe is selling in a store nearby.
- Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
CAREvolution is a venture capital firm that invests in healthcare sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, GovTech
- Stage:Seed, Venture - Series Unknown
- Geography: Belgium, United States
Investor stats
- Total investments: 4
- Round size: Seed $1.2M–$4.5M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Hoplr — Hoplr activates the social capital in your neighbourhood such as material, knowledge, time and infrastructure. Hoplr is a digital participation platform for inclusion, citizen participation and neighbourhood care.
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $236M in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 158
- Round size: Seed $120k–$5.6M; Series A $5.1M–$30M; Series B $12M–$96M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2017
Portfolio highlights
- Hearvana — Hearvana is a IT consulting company.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Fable Studio — Fable is building next-generation AI authoring tools to create interactive characters who can live, learn and make decisions with us.
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Belgium, France, United Kingdom
Investor stats
- Total investments: 48
- Round size: Seed $82k–$2.1M; Series A $422k–$14M; Series B $165k–$21M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
- Octave — Optimize energy use with Octave's battery storage (BESS) and energy management system (EMS). Reduce costs, increase flexibility.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We empower high-potential entrepreneurship and democratize venture capital. Discover promising start-ups & SMEs and invest alongside business angels.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Belgium, France
Investor stats
- Total investments: 26
- Round size: Seed $165k–$627k; Pre-Seed $150k–$197k; Series A $247k–$2.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Jelloow — Jelloow your virtual marketing navigator. Matching brands with likeminded marketing agencies.
- PlayTreks — Supercharge your music business with PlayTreks, the all-in-one workspace for music professionals. Built for indie artists, artist managers and label teams.
- NietsCo — NietsCo. is the home of Botaniets Gin 0.0%, a leading selection of alcohol-free products, carefully distributed to the world's best restaurants, concept stores, shops and consumers.
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Series A $768k–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
- Cell Matters — Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage. It offers an integrated set of GMP services, in line with regulatory, quality, and GMP requirements of the cell therapy industry.
- Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Sensinnovat
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, France
Investor stats
- Total investments: 5
- Round size: Seed $5.2M–$7.3M; Series A $7.3M–$17M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Hummink — Dream Smaller Now : Experience a revolution with Hummink's world's smallest fountain pen. Redefine micro-scale writing with our innovative technology.
- Azalea Vision — Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders.
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
Manuardeo is an early stage investments focused VC firm.
Show more...Investment focus
- Industry: TV, Video, Mobile
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Belgium, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aperi — True virtualization - live IP media - low-latency live sports remote production and distribution
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, Belgium
Investor stats
- Total investments: 12
- Round size: Series A $10M–$197M; Series B $7M–$23M; Series C $21M–$45M
- Lead/follow: 67% lead, 33% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
- Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
- Alveus Therapeutics — At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.
Specializes in spin-off and spin-out investments.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 3
- Round size: Seed $1.4M–$4.3M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
- Synergia Medical — Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators.In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputeeprosthesis arm and developed its first version of the NAOS platform.Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 116
- Round size: Seed $795k–$3M; Series A $1.6M–$6.6M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $76M in 2022
Portfolio highlights
- CleverCards — The Platform for Contactless Cards. The CleverGift real-time payment platform offers gift cards, expenses, employee incentives, and travel foreign exchange.
- Bloomberg PolarLake — Streamline the acquisition, management and distribution of instrument, pricing, index, legal and ratings data from multiple delivery channels.
- WhatClinic.com — WhatClinic.com helps patients find, compare and book the right clinics for them, in more than 135 countries. They provide detailed listings for over 120,000 clinics on their site. These include doctors, dentists, beauty and cosmetic surgery, physiotherapy, fertility, holistics and a lot more. They believe that every patient is an empoweredconsumer.
Sofinex is an investment comapny.
Show more...Investment focus
- Industry: Wellness, Lifestyle, Health Care
- Stage:Series A
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Parana Management
Show more...Investment focus
- Industry: Medical, Diabetes, Health Care
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
Guiding health technology towards a brighter future.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Pre-Seed
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Koios Care — Koios Care is a startup in the field of digital health. Their objective is to develop innovative and validated digital daily activity biomarkers in order to improve care while lowering costs.
- Nuclivision — Nuclivision is a company of experts assisting businesses, doctors and clinics all along the imaging workflow
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 237
- Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $154M in 2026
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
- Zenchef — Zenchef was created in 2010 and has more than 7000 customers in 15 different countries. Zenchef has developed a complete customer experience management tool (before, during and after the service) without commission or intermediary for restaurateurs. The restaurant owner remains independent! With only one software, manage all your reservations, yourwebsite, your digital menus, the click & collect, your reviews, your customer file, the digital payment by QR Code, your marketing campaigns...
A multi-industry early stage venture capital fund Nausicaa Ventures is an early stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. Nausicaa Ventures was created in 2009 by bringing together 35 private investors and selected institutional investors, such as the European Investment Fund or ING Bank, under the management of ...
Show more...Investment focus
- Industry: Software, CRM, Big Data
- Stage:Series B
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NGDATA — NGDATA is the consumer intelligence management solutions company that empowers enterprises seeking greater customer lifetime value to drive continuous, actionable insights to enable sales and increase customer loyalty.The company does this through its unique combination of Big Data management and machine learning technologies in a singleintegrated solution.Recently named one of Bank Systems and Technology Magazine’s “Top 7 Big Data Players to Watch,” NGDATA is headquartered in Ghent, Belgium with offices in New York City and San Francisco. The company provides solutions to data-driven sectors such as financial services, retail and media/publishing.
- Ovizio — Ovizio develops digital holographic interferometric microscopy products. It builds 4D microscopic imaging devices and software based on digital holographic microscopy. Ovizio offers oLine 4D, a research and development, and diagnostic desktop device that is used without specific sample preparation, as well as with automatic compensation ofscratches or distortions on the sample support; iLine 4D, a multipurpose device for applications, such as inline or online flow monitoring or direct monitoring of cell cultures in bioreactors; and OsOne software for visualization, analysis, and archiving of images captured by the imaging devices. It also provides ILine F, a device that captures suspension cell culture process in real time; iLine M, an instrument that monitors cell confluence in multi layer vessels; iLine S, an equipment that monitors reproducibility of fragile cell; and QMod, a holographic and fluorescene microscopy. Scientists in the areas of pharmaceutical and biotech research and development use the products of Ovizio. Philip Mathuis and Serge Jooris founded it in 2009, with its headquarters in Brussels in Belgium.
start-ups, SMEs, technology, co-investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Germany, The Netherlands, Austria
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Filuta AI — Operationalized Composite Artificial Intelligence
- Resistell AG — Resistell is a antibiotic resistance test.
- iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 217
- Round size: Series A $7.3M–$115M; Series B $15M–$150M; Series C $15M–$94M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $650M in 2016
Portfolio highlights
- NextCure — NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
- Spark Therapeutics — Breakthrough science. One moment, one day, one person at a time.
- Marinus Pharmaceuticals — Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. Samsara BioCapital, as a results-driven organization, is always looking for ambitious and visionary partners with the drive and flexibility to take their company to the next level. Samsara BioCapital promotesbiotech innovation and collaborates with inspiring companies as they develop important and innovative new therapies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Post-IPO Equity
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 176
- Round size: Series A $42M–$200M; Series B $33M–$200M; Post-IPO Equity $40M–$200M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Gossamer Bio — Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focuson areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
- Psivant Therapeutics — Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
- Palvella Therapeutics — Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A
- Geography: Belgium, The Netherlands
Investor stats
- Total investments: 62
- Round size: Seed $1.3M–$7.4M; Series A $1.6M–$34M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Firecell — Firecell is a Telecommunications Industry.
- Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
- Sightera Biosciences — Revolutionizing drug discovery through AI-powered analysis of patient-derived models for breakthrough therapeutics in cancer and regenerative medicine.
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 42
- Round size: Series A $4.3M–$49M; Series B $12M–$75M; Series C $5.6M–$250M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
- Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
- Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
SHIGERU AG is a technology company that leverages technological innovation to enable a new way of life.
Show more...Investment focus
- Industry: Blockchain, Cloud Computing, Virtual Reality
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Japan, Belgium
Investor stats
- Total investments: 7
- Round size: Seed $3.5M–$7.3M; Pre-Seed $1M–$3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- DR. PECKER INC. — DR. PECKER is AI & generative AI driven, smart clinics & health tech software solutions, platform and services provider. The industries the company tackles are augmented & immersive user experience in smart clinics & heath tech, medical research, humanity with Meta Verse & Multi Verse extensions.
- RAI — RAI is a mixed reality, generative AI, metaverse, and multiverse software solutions, platforms, and services provider. The industries the company tackles are augmented workspaces, heath tech, media and streaming, humanity, XR/MR + AI, and Meta Verse
- Thunderbirds — Fintech | XR/MR + AI | Metaverse & Multiverse
Investsud is a capital firm that works on investments in different industries including food, general industry, and technological startup.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: Belgium, France
Investor stats
- Total investments: 12
- Round size: Seed $546k–$24M; Series A $4.9M–$29M; Series B $21M–$26M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed
- Geography: The Netherlands, Belgium, United States
Investor stats
- Total investments: 54
- Lead/follow: no public data
Portfolio highlights
- Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 107
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 169
- Round size: Series A $16M–$200M; Series B $38M–$165M; Series C $14M–$208M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $470M in 2023
Portfolio highlights
- Ousia Pharma — Ousia Pharma is paving the way for novel therapeutic strategies using peptide-drug-conjugates
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
New Economy Startups Investor & Accelerator
Show more...Investment focus
- Industry: Software, Music, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Belgium, France, United States
Investor stats
- Total investments: 47
- Round size: Seed $357k–$2M; Series A $257k–$12M; Venture - Series Unknown $830k–$19M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
- Gamevestor — Be more than a player. Invest in expert-selected video game projects and earn a share of their commercial revenues.
- CityLegends — A home for urban sports & culture partners of CityLegends. Making the lines.
Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, Canada, France
Investor stats
- Total investments: 21
- Round size: Seed $566k–$18M; Series A $1.3M–$41M; Venture - Series Unknown $3.6M–$20M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Icentia — Icentia provides a range of innovative medical tests for healthcare institutions. They are able to offer valuable solutions for major problems in the field of medical testing.
- Simmunome AI — We use AI to create accurate, comprehensive disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to gain insights, make go/no-go decisions, and de-risk your pipeline, getting you to market faster and reducing your R&D co
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 188
- Round size: Series A $7.3M–$78M; Series B $11M–$114M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $282M in 2023
Portfolio highlights
- ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
- Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Qbic is the result of a lot of thinking, debating and sketching of what a city hotel could be; one that breaks the rules and makes people smile.An astonishing level of change has swept through the world over the last few years. But the hotel experience is no different than it’s ever been: stuffy, over-priced and lacking soul. They’re here tochange all that. they’re curious, imaginative and friendly, and they think there are lots of people just like us seeking a hotel with personality in the middle of the city.They believe in something better than what’s currently out there. A place that celebrates life rather than sucks life out of it. A hotel that’s built on creativity and a belief that you don’t have to accept the conventional. Somewhere that sends you away with fun stories and ideas, and is easy on your pocket.
Show more...Investment focus
- Industry: Health Care, Biotechnology, AgTech
- Stage:Seed, Series B
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $3.7M–$11M; Series B $8.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
- Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 158
- Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $44M in 2021
Portfolio highlights
- AlephD — The programmatic performance company
- Stootie — Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick!This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime.The keywords of Stootie are : marketplace, P2P business, local,mobile, realtime, platform.Stootie is currently available on iOS and Android.
- Voluntis — Voluntis design digital therapeutics to people across multiple areas to self-manage their treatment improving real-world outcomes.
Founded in 1997, Earlybird is a pan-European VC investor backing tech-enabled companies and investing in their growth and development. Funds include Earlybird, Earlybird Health, Growth Opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 386
- Round size: Seed $1.4M–$14M; Series A $4.4M–$35M; Series B $6M–$75M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $422M in 2026
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- ColibrITD — ColibriTD leader of Simulation solutions using Quantum computing
- Neuracore — The robot skill creation engine: collect demonstrations, curate datasets, train imitation and reinforcement learning policies, and deploy them on real robots, all on one platform.
Fonds Vives II (University of Louvain, UCL)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Belgium, United States
Investor stats
- Total investments: 5
- Round size: Series A $9.9M–$16M; Series B $6.6M–$75M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Virovet — Antiviral drugs and thermostable vaccines for livestock
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
Medical Device VC funding in Belgium at a glance
Stats across 102 deals from 143 investors.
Access all 143 VC funds in Belgium Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 143 VC funds investing in Belgium Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!